相关实验视频

Updated: Jul 16, 2025

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.3K

基于dithranol-imiquimod的优化过皮免疫可以使瘤被排斥.

Ann-Kathrin Hartmann1, Joschka Bartneck1, Jonas Pielenhofer2

  • 1IIIrd Department of Medicine - Hematology and Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.

Frontiers in immunology
|September 20, 2023
PubMed
概括

使用DIVA平台与dithranol和imiquimod (IMQ) 进行优化穿皮免疫 (TCI),可以增强T细胞的反应. 这种非侵入性方法有效控制瘤生长,对癌症疫苗有希望.

关键词:
细胞毒性T淋巴细胞 (CTL)迪特兰醇 (安特拉林) 是一种伊米基莫德 (IMQ) 是一种通过皮肤免疫接种.瘤的排斥 瘤的排斥

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.6K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554